Baird hosted Dr. Jonathan Barratt of University of Leicester-notably excited for new therapies that can quiet autoimmune activity driving pathogenesis,where he sees APRIL, BAFF+APRIL, earlier-stage therapeutics like BHV-1400 $BHVN impressive potential to transform standard ofcare